293 related articles for article (PubMed ID: 35882185)
1. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Patients with Philadelphia-Negative Myeloproliferative Neoplasm: A Single Center Experience.
Ali EAH; Khamees I; Alshurafa A; Qasim H; Abu-Tineh MA; Ahmed K; Saad E; Yassin M
Oncology; 2022; 100(8):460-466. PubMed ID: 35882185
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the factors influencing the severity of coronavirus disease 2019 in patients with myeloproliferative neoplasms based on an online questionnaire].
Qi FY; Bao M; Gao HL; Jiang Q
Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):371-377. PubMed ID: 38561282
[No Abstract] [Full Text] [Related]
3. Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Marchetti M; Salmanton-García J; El-Ashwah S; Verga L; Itri F; Ráčil Z; Dávila-Valls J; Martín-Pérez S; Van Doesum J; Passamonti F; Abu-Zeinah G; Farina F; López-García A; Dragonetti G; Cattaneo C; Gomes Da Silva M; Bilgin YM; Žák P; Petzer V; Glenthøj A; Espigado I; Buquicchio C; Bonuomo V; Prezioso L; Meers S; Duarte R; Bergantim R; Jaksic O; Čolović N; Blennow O; Cernan M; Schönlein M; Samarkos M; Mitra ME; Magliano G; Maertens J; Ledoux MP; Jiménez M; Demirkan F; Collins GP; Cabirta A; Gräfe SK; Nordlander A; Wolf D; Arellano E; Cordoba R; Hanakova M; Zambrotta GPM; Nunes Rodrigues R; Limberti G; Marchesi F; Cornely OA; Pagano L
Ther Adv Hematol; 2023; 14():20406207231154706. PubMed ID: 36923264
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
Ali EA; Khamees I; Abu-Tineh M; Qasim H; Alshurafa A; Ahmed K; Malkawi L; Yassin MA
Cureus; 2022 Apr; 14(4):e23863. PubMed ID: 35411288
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
6. Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Boddu P; Masarova L; Verstovsek S; Strati P; Kantarjian H; Cortes J; Estrov Z; Pierce S; Pemmaraju N
Ann Hematol; 2018 Jan; 97(1):109-121. PubMed ID: 29143068
[TBL] [Abstract][Full Text] [Related]
7. Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities.
Coltro G; Loscocco GG; Vannucchi AM
Int Rev Cell Mol Biol; 2021; 365():1-69. PubMed ID: 34756241
[TBL] [Abstract][Full Text] [Related]
8. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
[TBL] [Abstract][Full Text] [Related]
10. [New aspects of myeloproliferative neoplasms: COVID-19 and myeloproliferative neoplasms].
Shide K
Rinsho Ketsueki; 2022; 63(6):647-654. PubMed ID: 35831201
[TBL] [Abstract][Full Text] [Related]
11. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS
Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
13. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ortuzar A; Fox ML; Vera JA; Lorenzo Vizcaya Á; Marín Sánchez A; Llopis Calatayud I; Carbonell S; Álvarez-Larrán A; Mata Serna R; Marco Buades JE; Quiroz Cervantes K; Martínez Hellín Á; Blum Domínguez A; Caballero Navarro G; Cáceres Sansaloni A; Guerrero Fernández L; Muñoz Linares C; Gasior Kabat M; Pérez López R; Fernández Rodríguez Á; Martínez Bilbao C; Cobo Rodríguez MT; Díaz Á; Durán MA; Santaliestra Tomas M; García-Gutierrez V; Magro Mazo E; Hernández-Boluda JC; Segura A; Raya JM; Navas Elorza B; Osorio S
Ann Hematol; 2023 Feb; 102(2):447-456. PubMed ID: 36422672
[TBL] [Abstract][Full Text] [Related]
17. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
[TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms.
Krečak I; Peran N; Lapić I; Gverić-Krečak V; Krečak F; Rončević P; Duraković N
Wien Klin Wochenschr; 2021 Jan; 133(1-2):62-64. PubMed ID: 32300883
[TBL] [Abstract][Full Text] [Related]
19. Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
Kaifie A; Isfort S; Gattermann N; Hollburg W; Klausmann M; Wolf D; Maintz C; Hänel M; Goekkurt E; Göthert JR; Platzbecker U; Geer T; Parmentier S; Jost E; Serve H; Ehninger G; Berdel WE; Brümmendorf TH; Koschmieder S;
Ann Hematol; 2016 Sep; 95(9):1399-410. PubMed ID: 27334946
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia.
Malhotra J; Kremyanskaya M; Schorr E; Hoffman R; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):31-6. PubMed ID: 24220620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
